Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 3 8Phase 1/2 4Phase 2/3 2Phase 1 2

Status

Withdrawn 1Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Myelodysplastic Syndromes 5Leukemia 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myeloid, Acute 4Breast Neoplasms 4Lymphoma, Non-Hodgkin 3Lymphoma 3Ovarian Neoplasms 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Hematologic Neoplasms 2Carcinoma, Ovarian Epithelial 2Blast Crisis 2Shwachman-Diamond Syndrome 1Primary Immunodeficiency Diseases 1Neutropenia, Severe Congenital, Autosomal Recessive 3 1Neuroblastoma 1Neoplasms, Plasma Cell 1Macrophage Activation Syndrome 1Lymphohistiocytosis, Hemophagocytic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Biphenotypic, Acute 1Immunologic Deficiency Syndromes 1Hodgkin Disease 1Histiocytosis, Langerhans-Cell 1Histiocytosis 1High Risk Myeloid Malignancies 1Hemoglobinopathies 1

Interventions

Trastuzumab 62Paclitaxel 57Cyclophosphamide 44pembrolizumab 34Fulvestrant 34Capecitabine 29Carboplatin 26Docetaxel 23Letrozole 22Doxorubicin 19palbociclib 16abemaciclib 16pertuzumab 15durvalumab 14Filgrastim 13Everolimus 13ribociclib 12Lapatinib 12Gemcitabine 12exemestane 11eribulin 11Vinorelbine 11Albumin-Bound Paclitaxel 11Bevacizumab 10trastuzumab deruxtecan 9neratinib 9fludarabine 9Taxes 9Radiotherapy 9Peripheral Blood Stem Cell Transplantation 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Breast Neoplasms × Thiotepa × Clear all
NCT00003086 2020-07-14

Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer

Louisiana State University Health Sciences Center Shreveport

Phase 1/2 Terminated
12 enrolled
Breast

Breast Neoplasms

NCT00006123 2018-05-16

Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer

Dana-Farber Cancer Institute

Phase 1/2 Withdrawn
Breast

Breast Neoplasms

NCT00002780 2013-12-19

Biological Therapy in Treating Women With Metastatic Breast Cancer

National Cancer Institute (NCI)

Phase 1/2 Unknown
60 enrolled
Breast

Breast Neoplasms

NCT00003877 2011-03-07

Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer

Roswell Park Cancer Institute

Phase 1/2 Completed
30 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡